Garheng Kong insider trades

Open-market stock purchases and sales by Garheng Kong, Director at Xeris Biopharma Holdings, Inc, from SEC Form 4 filings since Mar 20, 2012.

Track record: 0% of 4 scored buys are up 5% or more since purchase, averaging -87%.

Recent trades

DateStockTradeValue
Jun 4, 2026XERS Xeris Biopharma Holdings, IncBought (not open market)—
Jun 4, 2026XERS Xeris Biopharma Holdings, IncBought (not open market)$203K
Feb 11, 2026LH Labcorp Holdings IncBought (not open market)—
Feb 10, 2026LH Labcorp Holdings IncBought (not open market)—

Companies traded

  • XERS Xeris Biopharma Holdings, Inc: other filings, last Jun 4, 2026
  • LH Labcorp Holdings Inc: other filings, last Feb 11, 2026
  • VERO Venus Concept Inc: 4 buys, last Mar 24, 2023
  • ALIM Alimera Sciences Inc: other filings, last Jan 4, 2023
  • SBBP Strongbridge Biopharma plc: other filings, last Oct 5, 2021
  • AVDR Avedro Inc: 1 buy, last Nov 21, 2019
  • HSGX Histogenics Corp: other filings, last Jun 15, 2018
  • MLNT Melinta Therapeutics, Inc /new/: other filings, last Jun 12, 2018
  • CEMP Cempra, Inc: 1 buy, last Jan 3, 2017

Get free alerts when Garheng Kong files a new trade →